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General Synthetic Methods
All non-aqueous reactions were carried out under an atmosphere of nitrogen using oven-dried glassware that was cooled in a desiccator prior to use. Unless otherwise noted, starting materials and reagents were obtained from commercial suppliers and were used without further purification. Toluene, THF, CH2Cl2, and Et2O were dried and purified by passage through activated alumina columns using a Glass Contour Solvent Purification System. N,NDiethylaniline and Et3N were distilled from calcium hydride and stored over molecular sieves under a nitrogen atmosphere. Saturated aqueous solutions of inorganic salts are represented as (volume, sat aq). 1 H and 13 C NMR spectra were obtained on Bruker instruments at the stated frequency. Infra-red spectra were recorded neat on Shimadzu IRAffinity-1 unless otherwise stated. Electrospray (ESI) and electron ionisation (EI) mass spectra were obtained on a Kratos MS50TC mass spectrometer. Melting points were determined on a Gallenkamp
Electrothermal Melting Point apparatus and are uncorrected. Flash chromatography was carried out using Merck [1]
-S3-
Experimental Procedures for Synthesis of 4-MeProTz Fragment 1,2-Di-tert-butyl (2S,4S)-4-methylpyrrolidine-1,2-Dicarboxylate 5
DIPEA (0.090 mL, 0.54 mmol) was added to a stirred solution of 4-methyl proline tert-butyl ester 4 [2] (0.10 g, 0.54 mmol) in DCM (10 mL) at rt. Di-tert-butyl-dicarbonate (0.12 g, 0.54 mmol) was added and the reaction mixture was stirred for ~18 h at rt. The reaction mixture was then washed with HCl (2 × 10 mL; 1 M aq), H2O (2 × 10 mL), NaHCO3 (10 mL; sat aq) and brine (10 mL; sat aq) and dried with anhydrous MgSO4. The solvent was removed in vacuo to give the desired product 5 as colourless oil in sufficient purity for the next reaction (0.15 g, 95% 
tert-Butyl (2S,4S)-2-formyl-4-methylpyrrolidine-1-carboxylate 6
DIBAL (1.3 mL, 1.3 mmol; 1 M in hexanes) was added dropwise over 20 min to a stirred solution of Boc-protected 4-methyl proline tert-butyl ester 5 (0.15 g, 0.53 mmol) in DCM (100 mL) at -78 °C. The reaction mixture was stirred for 2 h at -78 °C then MeOH (10 mL) was added dropwise. The reaction mixture was transferred to an ice bath and citric acid (50 mL; 0.5 M aq) was added dropwise with vigorous stirring. The reaction mixture was allowed to return to rt then extracted with EtOAc (2 × 100 mL). The combined organic extracts were then washed with H2O (100 mL) and brine (100 mL; sat aq) and dried with anhydrous MgSO4. The solvent was removed in vacuo and the crude product was then purified using column chromatography (EtOAc:hexane, 1:4) to give the desired product 6 as a colourless oil (0.11 g, 97% Methyl ester 8 (0.13 g, 0.40 mmol) was dissolved in MeOH (2 mL) and THF (4 mL) and stirred at 0 ºC. NaOH (0.50 mL, 0.50 mmol; 1 M aq) was added dropwise and the reaction was allowed to return to rt and stirred for a further 24 h. The reaction was then cooled to 0 ºC and acidified to pH 2 by dropwise addition of HCl (1 M aq). The reaction mixture was concentrated in vacuo to remove the organic solvents, then extracted with DCM (3 × 10 mL). The combined organic phases were washed with H2O (10 mL), dried with anhydrous MgSO4 and concentrated in vacuo. The resulting white crystalline solid 9 was judged to be pure enough for use in SPPS (0.10 g, 80%). Rf 
Experimental Procedures for Synthesis of NMe-D-BrTyr Fragment
Methyl (2R)-3-(3-Bromo-4-tert-butoxy-phenyl)-2-(tert-butoxycarbonylamino)-propanoate 11
Phenol 10 [3] (4.08 g, 10.9 mmol) and Sc(OTf)3 (0.271 g, 0.553 mmol) were dissolved in DCM (40 mL) at rt. Di-tert-butyl-dicarbonate (14.3 g, 65.4 mmol) was added and the reaction was monitored by TLC (vanillin dip). Extra portions of di-tert-butyldicarbonate (4.76 g, 21.8 mmol) were added if the TLC indicated it was no longer present. When the reaction was judged complete it was quenched with H2O (40 mL) and the aqueous phase was extracted with DCM (3 × 40 mL). The combined organic phases were dried with anhydrous MgSO4 and concentrated in vacuo. The crude product was purified by column chromatography (DCM)
to give the desired product 11 as a colourless oil (3.04 g, 65% 
Methyl (2R)-3-(3-Bromo-4-tert-butoxy-phenyl)-2-(tert-butoxycarbonylmethylamino)-propanoate 12
Carbonate 11 (2.32 g, 5.40 mmol) was dissolved in dry THF (50 mL) and stirred at 0 ºC. NaH (0.320 g, 8.10 mmol, 60% dispersion in mineral oil) was added in small portions and the reaction was stirred for 15 min at 0 ºC. A solution of MeI (2.69 mL, 43.2 mmol) in DMF (10 mL) was then added and the reaction was stirred for a further 60 min at 0 ºC before being allowed to return to rt and stirred for 18 h. The reaction mixture was diluted with EtOAc (100 mL) then quenched with NaHCO3 (100 mL; sat aq). The aqueous phase was extracted with EtOAc (3 × 100 mL) and the combined organic phases were washed with brine (100 mL; sat aq) then dried with anhydrous MgSO4. The solvent was removed in vacuo and the crude product was purified by column chromatography (DCM:MeOH, 98:2) to give the desired product 12 as a colourless oil (1.75 g, 73%). Rf 
(2R)-3-(3-Bromo-4-tert-butoxy-phenyl)-2-(tert-butoxycarbonylmethylamino)-propionic acid 13
Methyl ester 12 (4.51 g, 10.2 mmol) was dissolved in MeOH (20 mL) and THF (40 mL) and stirred at 0 ºC. NaOH (13 mL, 12.7 mmol, 1 M aq) was added dropwise and the reaction was allowed to return to rt and stirred for a further 24 h. The reaction was then cooled to 0 ºC and acidified to pH 2 by dropwise addition of HCl (1 M aq). The reaction mixture was concentrated in vacuo to remove the THF and MeOH, then extracted with DCM (3 × 100 mL). The combined organic phases were washed with H2O (100 mL), dried with anhydrous MgSO4 and concentrated in vacuo. The resulting colourless oil 13 was judged to be pure enough for use without further purification (3.85 g, 88% Chloranil test was performed and coupling was repeated if any blue beads were observed.
Fmoc deprotection:
20% Piperidine in DMF (3 mL) was added to the resin and the resin was agitated for 10 min at rt. This was repeated with fresh solution for a further 10 min, then the resin was washed with DMF (3 × 3 cm 
Boc Deprotection:
A 1:1 mixture of TFA and DCM (4 mL) was added to the resin and the resin was agitated for 5 min. This was repeated with fresh solution for a further 20 min, then the resin was washed with DCM (3 × 3 cm 3 ), MeOH (3 × 3 cm 3 ) and DCM (3 × 3 cm 3 ). The Chloranil test was performed and the coupling was repeated if any colourless beads were observed.
Selective Boc deprotection:
The resin was solvated in dry DCM (5 mL) and chilled (dry ice) before addition of 2,6-lutidine (242 L, 2.10 mmol, 15 eq.) and TMSOTf (304 L, 1.68 mmol, 12 eq.). The resin was agitated at 78 ºC for 15 min then for a further 90 min at rt. The reaction mixture was removed and the resin washed with DCM (3 × 3 cm 3 ), MeOH (3 × 3 cm 3 ) and DCM (3 × 3 cm 3 ). TBAF (3 mL, 1 M in THF) was then added and the resin was agitated for 10 min.
This was repeated with fresh solution, then the resin was washed with DCM (3 × 3 cm 3 ), MeOH (3 × 3 cm 3 ) and DCM (3 × 3 cm 3 ). The Chloranil test was performed and the coupling was repeated if any colourless beads were observed.
Amino Acid coupling:
The Boc or Fmoc-protected amino acid residue (0.41 mmol, 3.00 eq.) and Oxyma (0.06 g, 0.41 mmol, 3.00 eq.)
were dissolved in DMF (2 cm 3 ) and DIC (64.1 L, 0.41 mmol, 3.00 eq.) was added. The reaction mixture was agitated for 5 min before addition to the resin,* and the resin was then agitated for 1 h at rt. The reaction mixture was removed and the resin washed with DMF (3 × 3 cm 3 ), DCM (3 × 3 cm 3 ), MeOH (3 × 3 cm 3 ) and DCM (3 × 3 cm 3 ). The Chloranil test was performed and the coupling was repeated if any blue beads were observed.
* If the coupling step followed a Boc deprotection then DIPEA (36.6 L, 0.210 mmol, 1.50 eq.) was also added to the resin at this point.
Cleavage of Peptide from Rink Amide:
A mixture of TFA:TIS:H2O (3 cm 3 , 95:2.5:2.5) was added to the resin and the resin was agitated at rt for 3 h. The reaction solution was filtered and collected, then evaporated to dryness under nitrogen. The resulting residue was cooled in an ice bath and cold ether was added until a colourless precipitate formed. The suspension was cooled (dry ice) to ensure complete precipitation, then centrifuged (5000 rpm, 5 min), and the ether poured off before fresh ether (15 cm 3 ) was added. Sonication was used to re-mobilise the precipitate and the suspension was centrifuged again (5000 rpm, 5 min). The ether was then decanted and the resulting white pellet purified to obtain the desired product.
Spectroscopic Data for Tz-BBA analogues Bis1-6
Piv-Ala-(NMe-D-BrTyr)-(4-MePro-Tz)-(D-Leu)-(NMe-Phe)-Opp Bis1
Amino Acid 
Piv-Ala-(NMe-D-BrTyr)-(4-MePro-Tz)-(D-Leu)-(NMe-Phe)-Ala-NH2 Bis2
Piv-Ala-(NMe-D-BrTyr)-(4-MePro-Tz)-(D-Leu)-Ala-Opp Bis3
Amino Acid IKK alpha/beta P Ser176/Ser177 mTOR mTOR P Ser2448
Data for Reverse Phase Protein Microarray Assays
NFkB p65 Ser536
PLC-gamma1 P Tyr783 SHP2 P Tyr542
4E-BP1 P Ser65
Akt Akt P Ser473
Akt P Thr308
AMPK alpha P Thr172
Bad P Ser112
Bcl-2 beta-Catenin Bid Bim P Ser69
Caspase 3
Caspase 3 cleaved
Chk1 P Ser345
Cyclin D1 P Thr286 Only 24 h time point data from selected analogues is shown.
